Pemetrexed and TAS-102 in Combination With Bevacizumab in Refractory Colorectal Cancer
Clinical trial NCT04683965 · UNKNOWN
Trial details
- NCT number
- NCT04683965
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2024-01-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.